tiprankstipranks
Fennec Pharmaceuticals (FENC)
NASDAQ:FENC
US Market
FENC
Fennec Pharmaceuticals
RESEARCH TOOLSreports

Fennec Pharmaceuticals (FENC) Financial Statements

255 Followers

Fennec Pharmaceuticals Financial Overview

Fennec Pharmaceuticals's market cap is currently $224.99M. The company's EPS TTM is $-0.16892553600000002; its P/E ratio is -21.47; Fennec Pharmaceuticals is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 45.42M$ 47.54M$ 21.25M$ 1.53M$ 0.00
Gross Profit$ 41.59M$ 44.35M$ 19.99M$ 1.45M$ 0.00
Operating Income$ -6.86M$ 2.57M$ -12.77M$ -22.59M$ -17.22M
EBITDA$ -6.86M$ 4.80M$ -12.65M$ -22.74M$ -17.18M
Net Income$ -10.27M$ -436.00K$ -16.05M$ -23.86M$ -17.46M
Balance Sheet
Cash & Short-Term Investments$ 36.72M$ 26.63M$ 13.27M$ 23.77M$ 21.10M
Total Assets$ 70.07M$ 44.95M$ 26.86M$ 26.94M$ 22.41M
Total Debt$ 0.00$ 19.34M$ 30.95M$ 24.90M$ 4.99M
Net Debt$ -36.72M$ -7.29M$ 17.68M$ 1.13M$ -16.11M
Total Liabilities$ 35.02M$ 50.82M$ 38.49M$ 29.51M$ 6.64M
Stockholders' Equity$ 35.05M$ -5.87M$ -11.62M$ -2.57M$ 15.77M
Cash Flow
Free Cash Flow$ -14.67M$ 26.98M$ -17.14M$ -18.06M$ -14.22M
Operating Cash Flow$ -14.67M$ 26.98M$ -17.14M$ -18.06M$ -14.22M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 25.01M$ -13.62M$ 6.64M$ 20.73M$ 4.98M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

Income Statement >

Fennec Pharmaceuticals Debt to Assets

Balance Sheet >

Fennec Pharmaceuticals Cash Flow

Cash Flow >

Fennec Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >